The strategy to suppress the expression level of CXCL1 could effectively decrease the VCAM-1 expression, which has the beneficial response for inhibiting migration, invasion, and wound healing abilities in osteosarcoma. This evidence concerns the gene CXCL1 and osteosarcoma.